Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Brandon Henry and Fabian Sanchis-Gomar.
Connection Strength

6.454
  1. Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis. Clin Chem Lab Med. 2022 01 26; 60(1):e1-e3.
    View in: PubMed
    Score: 0.241
  2. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection. Ann Intern Med. 2021 06; 174(6):885-886.
    View in: PubMed
    Score: 0.237
  3. Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study. J Clin Pathol. 2021 Mar 31.
    View in: PubMed
    Score: 0.234
  4. Response to: Eosinophil count in coronavirus disease 2019: more doubts than answers. QJM. 2021 02 18; 114(1):70-71.
    View in: PubMed
    Score: 0.233
  5. Pooled analysis of monocyte distribution width in subjects with SARS-CoV-2 infection. Int J Lab Hematol. 2021 08; 43(4):O161-O163.
    View in: PubMed
    Score: 0.232
  6. Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA. Eur J Hosp Pharm. 2021 Jan 27.
    View in: PubMed
    Score: 0.232
  7. CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients. Acad Radiol. 2021 03; 28(3):440-441.
    View in: PubMed
    Score: 0.231
  8. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness. Semin Thromb Hemost. 2021 06; 47(4):460-462.
    View in: PubMed
    Score: 0.230
  9. Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress. Eur J Psychiatry. 2021 Jul-Sep; 35(3):200-201.
    View in: PubMed
    Score: 0.229
  10. Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? J Diabetes. 2021 02; 13(2):179-180.
    View in: PubMed
    Score: 0.228
  11. Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. J Diabetes. 2020 Nov; 12(11):851-855.
    View in: PubMed
    Score: 0.228
  12. Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc. 2021 01; 96(1):203-217.
    View in: PubMed
    Score: 0.228
  13. Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing. Infect Control Hosp Epidemiol. 2021 11; 42(11):1405-1406.
    View in: PubMed
    Score: 0.228
  14. In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19. Mayo Clin Proc. 2020 11; 95(11):2561-2563.
    View in: PubMed
    Score: 0.226
  15. Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 2019. Acta Haematol. 2021; 144(4):360-364.
    View in: PubMed
    Score: 0.225
  16. Repeated Testing in SARS-CoV-2 Infection. Mayo Clin Proc. 2020 10; 95(10):2283-2284.
    View in: PubMed
    Score: 0.224
  17. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Clin Chem Lab Med. 2020 08 27; 58(9):1415-1422.
    View in: PubMed
    Score: 0.222
  18. Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. J Med Virol. 2020 10; 92(10):1759-1760.
    View in: PubMed
    Score: 0.221
  19. COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon. Ann Transl Med. 2020 Jun; 8(11):693.
    View in: PubMed
    Score: 0.221
  20. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis (Berl). 2020 05 26; 7(2):85-90.
    View in: PubMed
    Score: 0.221
  21. In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Mayo Clin Proc. 2020 07; 95(7):1553-1556.
    View in: PubMed
    Score: 0.221
  22. Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. Mayo Clin Proc. 2020 07; 95(7):1445-1453.
    View in: PubMed
    Score: 0.221
  23. Active smoking and COVID-19: a double-edged sword. Eur J Intern Med. 2020 07; 77:123-124.
    View in: PubMed
    Score: 0.220
  24. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. Curr Probl Cardiol. 2020 Aug; 45(8):100617.
    View in: PubMed
    Score: 0.220
  25. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19). Eur J Prev Cardiol. 2020 06; 27(9):906-908.
    View in: PubMed
    Score: 0.219
  26. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. Mayo Clin Proc. 2020 06; 95(6):1222-1230.
    View in: PubMed
    Score: 0.219
  27. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. Ann Transl Med. 2020 Apr; 8(7):497.
    View in: PubMed
    Score: 0.219
  28. Searching for a clinically validated definition of "asymptomatic" COVID-19 infection. Int J Clin Pract. 2021 Sep; 75(9):e14085.
    View in: PubMed
    Score: 0.060
  29. Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreak. EJIFCC. 2021 Feb; 32(1):69-77.
    View in: PubMed
    Score: 0.058
  30. Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis. Semin Thromb Hemost. 2021 Jun; 47(4):392-399.
    View in: PubMed
    Score: 0.058
  31. SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a meta-analysis. Acta Biomed. 2020 09 07; 91(3):e2020014.
    View in: PubMed
    Score: 0.056
  32. Updates on laboratory investigations in coronavirus disease 2019 (COVID-19). Acta Biomed. 2020 09 07; 91(3):e2020030.
    View in: PubMed
    Score: 0.056
  33. COVID-19 and obesity: links and risks. Expert Rev Endocrinol Metab. 2020 07; 15(4):215-216.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.